Cargando…
Efficient Delivery and Nuclear Uptake Is Not Sufficient to Detect Gene Editing in CD34+ Cells Directed by a Ribonucleoprotein Complex
CD34+ cells are prime targets for therapeutic strategies for gene editing, because modified progenitor cells have the capacity to differentiate through an erythropoietic lineage. Although experimental advances have been reported, the associated experimental protocols have largely been less than clea...
Autores principales: | Modarai, Shirin R., Man, Dula, Bialk, Pawel, Rivera-Torres, Natalia, Bloh, Kevin, Kmiec, Eric B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992347/ https://www.ncbi.nlm.nih.gov/pubmed/29858048 http://dx.doi.org/10.1016/j.omtn.2018.01.013 |
Ejemplares similares
-
Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides
por: Rivera-Torres, Natalia, et al.
Publicado: (2017) -
Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides
por: Bialk, Pawel, et al.
Publicado: (2016) -
Precise and error-prone CRISPR-directed gene editing activity in human CD34+ cells varies widely among patient samples
por: Modarai, Shirin R., et al.
Publicado: (2020) -
Exon skipping induced by CRISPR-directed gene editing regulates the response to chemotherapy in non-small cell lung carcinoma cells
por: Banas, Kelly, et al.
Publicado: (2022) -
Regulation of Gene Editing Activity Directed by Single-Stranded Oligonucleotides and CRISPR/Cas9 Systems
por: Bialk, Pawel, et al.
Publicado: (2015)